Fidelity Health Care Sector remains in the hands of a topnotch team that employs a sound and differentiated approach. The strategy, which includes two mutual funds, retains its High People and Above Average Process ratings.
Fidelity Select Health Care Portfolio FSPHX
- NAV / 1-Day Return 29.23 / +0.44 %
- Total Assets 6.8B
-
Adj. Expense Ratio
0.620%
- Expense Ratio 0.620%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.39%
- Turnover 69%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 9:21 PM GMT+0
Morningstar’s Analysis FSPHX
Will FSPHX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 40.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 7.66 | 483M | Healthcare |
Danaher Corp | 6.75 | 425M | Healthcare |
Thermo Fisher Scientific Inc | 6.34 | 399M | Healthcare |
UnitedHealth Group Inc | 4.21 | 265M | Healthcare |
Johnson & Johnson | 3.83 | 241M | Healthcare |
AbbVie Inc | 3.59 | 226M | Healthcare |
argenx SE ADR | 2.11 | 133M | Healthcare |
Merck & Co Inc | 2.11 | 133M | Healthcare |
West Pharmaceutical Services Inc | 2.09 | 132M | Healthcare |
Ascendis Pharma AS | 1.94 | 122M | Healthcare |